Sidley Austin represented Vera Therapeutics, Inc. in the transaction. Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Contineum Therapeutics in the offering, and Sidley Austin represented the underwriters. Contineum Therapeutics, a clinical stage biopharmaceutical company,...
You must be a Standard 1 Year member to access this content.
Sidley represented Capricor Therapeutics, while Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo represented Cantor Fitzgerald in the transaction. Capricor Therapeutics, Inc. has completed the issuance and...
You must be a Standard 1 Year member to access this content.
Sidley advised Akeso Inc. on the deal. Akeso Inc. announced a high-profile US$5 billion collaboration and licensing agreement with Summit Therapeutics Inc. to out-license its breakthrough bispecific...
You must be a Standard 1 Year member to access this content.
